These findings have potential implications for treatment for HPS and OA1 in that inhibition or enhancement of melanoregulin, respectively, may be beneficial in modulating the ocular pigment phenotype of these individuals. This evidence concerns the gene MREG and Hermansky-Pudlak syndrome.